IMMU-58. REDUCED NEOANTIGEN EXPRESSION AS A POSSIBLE IMMUNE EVASION MECHANISM DURING GLIOMA PROGRESSION

Limited success of immune-based therapies in glioma might be in part due to the lack of enough neoantigens (neoAgs) that can be targeted by immune effector cells. In addition, gliomas also show dynamic clonal evolution over time, possibly leading to immunoediting during progression. In this study, w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Nejo, Takahide, Matushita, Hirokazu, Karasaki, Takahiro, Nomura, Masashi, Nagae, Genta, Takayanagi, Shunsaku, Tanaka, Shota, Takahashi, Satoshi, Kitagawa, Yosuke, Hana, Taijun, Koike, Tsukasa, Narita, Yoshitaka, Nagane, Motoo, Nishikawa, Ryo, Ueki, Keisuke, Aburatani, Hiroyuki, Mukasa, Akitake, Kakimi, Kazuhiro, Saito, Nobuhito
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216610/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.561
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares